Republic v Pharmacy and Poisons Board & another; Galaxy Pharmaceuticals Ltd (Ex parte Applicant) (Judicial Review Application E352 of 2025) [2026] KEHC 4863 (KLR) (Judicial Review) (15 April 2026) (Judgment)

Republic v Pharmacy and Poisons Board & another; Galaxy Pharmaceuticals Ltd (Ex parte Applicant) (Judicial Review Application E352 of 2025) [2026] KEHC 4863 (KLR) (Judicial Review) (15 April 2026) (Judgment)

The Respondent's cancellation of drug registration certificates was procedurally unfair, irrational, and ultra vires, as no evidence of a fair hearing was provided, mandatory procedures were not followed, and the Respondent improperly intervened in a commercial trademark dispute pending before the Commercial Court....

Source-derived case information.

Citation
[2026] KEHC 4863 (KLR)
Parties
Applicant: Republic; Respondent: Pharmacy and Poisons Board; Interested Party: Prism Life Sciences Ltd; Ex Parte Applicant: Galaxy Pharmaceuticals Ltd
Court
High Court
Jurisdiction
Kenya
Case Number
Judicial Review Application E352 of 2025
Procedural Posture
Judicial Review Application / Judgment
Outcome
Application allowed in part
Legal Topics
Judicial Review, Fair Administrative Action, Trademark Dispute, Drug Registration, Procedural Fairness, Ultra Vires, Legitimate Expectation
Source Language
en
Administrative Law Constitutional Law Intellectual Property Law Health Law Judicial Review Fair Administrative Action Trademark Dispute Drug Registration +3 more

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Downloadable case file Legal principles 4 Authorities cited 32 Party arguments 2 Amounts and remedies 2
Sign in to unlock

Parties

Republic

Applicant

Pharmacy and Poisons Board

Respondent

Prism Life Sciences Ltd

Interested Party

Galaxy Pharmaceuticals Ltd

Ex Parte Applicant

Procedural Posture

Judicial Review Application / Judgment

  1. 1 Whether the Respondent acted ultra vires and unlawfully in cancelling drug registration certificates
  2. 2 Whether the Respondent breached the ex-parte Applicant's constitutional and statutory right to fair administrative action
  3. 3 Whether the Respondent's decisions were irrational, unreasonable, and disproportionate

Ratio Decidendi

The Respondent's cancellation of drug registration certificates was procedurally unfair, irrational, and ultra vires, as no evidence of a fair hearing was provided, mandatory procedures were not followed, and the Respondent improperly intervened in a commercial trademark dispute pending before the Commercial Court. The six-month limitation period did not apply as there were no formal proceedings, and res judicata and sub judice were inapplicable due to procedural evolution and distinct issues.

Court Disposition

Application allowed in part

Orders

  • Certiorari issued quashing Notice of Intention to Cancel dated 26th March 2025 and decision of 22nd May 2025 cancelling registration certificates for forty pharmaceutical products.
  • Mandamus issued compelling Respondent to reinstate drug registration certificates, reissue retention certificates, and restore products onto official register/database.